https://www.grunenthal.com/ 2026-02-18 daily 0.5 https://www.grunenthal.com/world-free-of-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/company 2025-08-28 daily 0.5 https://www.grunenthal.com/responsibility 2025-11-05 daily 0.5 https://www.grunenthal.com/science 2026-04-01 daily 0.5 https://www.grunenthal.com/careers 2024-08-22 daily 0.5 https://www.grunenthal.com/creditors-grunenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room 2025-09-01 daily 0.5 https://www.grunenthal.com/searchresults 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/understanding-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights 2024-11-15 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-management 2024-11-15 daily 0.5 https://www.grunenthal.com/world-free-of-pain/initiatives 2025-06-04 daily 0.5 https://www.grunenthal.com/world-free-of-pain/patient-collaboration 2025-03-17 daily 0.5 https://www.grunenthal.com/company/we-are-gruenenthal 2024-08-30 daily 0.5 https://www.grunenthal.com/company/products 2026-04-02 daily 0.5 https://www.grunenthal.com/company/leadership 2025-03-25 daily 0.5 https://www.grunenthal.com/company/supervisory-board 2024-08-22 daily 0.5 https://www.grunenthal.com/company/compliance-ethics-transparency 2025-11-17 daily 0.5 https://www.grunenthal.com/company/partnering 2026-01-05 daily 0.5 https://www.grunenthal.com/company/global-capabilities 2025-01-15 daily 0.5 https://www.grunenthal.com/company/history 2025-04-17 daily 0.5 https://www.grunenthal.com/responsibility/our-responsibility-approach 2025-08-20 daily 0.5 https://www.grunenthal.com/responsibility/patient-support 2025-08-20 daily 0.5 https://www.grunenthal.com/responsibility/people-employees-partners-communities 2025-08-20 daily 0.5 https://www.grunenthal.com/responsibility/planet-sustainability-approach 2026-03-04 daily 0.5 https://www.grunenthal.com/responsibility/responsible-sourcing 2025-08-20 daily 0.5 https://www.grunenthal.com/responsibility/corporate-citizenship 2025-08-20 daily 0.5 https://www.grunenthal.com/responsibility/thalidomide 2025-04-17 daily 0.5 https://www.grunenthal.com/science/pain-research-and-development 2024-08-22 daily 0.5 https://www.grunenthal.com/science/research-and-development-collaboration 2024-08-22 daily 0.5 https://www.grunenthal.com/science/pipeline 2026-03-17 daily 0.5 https://www.grunenthal.com/press-room/stories 2025-02-14 daily 0.5 https://www.grunenthal.com/press-room/statements 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/corporate-publications 2025-08-04 daily 0.5 https://www.grunenthal.com/press-room/resources-image 2025-02-12 daily 0.5 https://www.grunenthal.com/press-room/resources-video 2025-03-11 daily 0.5 https://www.grunenthal.com/press-room/freely-licensed-images 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/contact 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/medical-information-enquiry 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/other-privacy-statements 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/disclaimer 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/responsible-usage-statement 2025-04-04 daily 0.5 https://www.grunenthal.com/footer-links/responsible-usage-statement-dk 2025-04-04 daily 0.5 https://www.grunenthal.com/footer-links/responsible-usage-statement-nor 2025-04-04 daily 0.5 https://www.grunenthal.com/footer-links/responsible-usage-statement-se 2025-04-04 daily 0.5 https://www.grunenthal.com/footer-links/general-terms-and-conditions 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/imprint 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/privacy-statement 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/datenschutzhinweis-nach-art-13-dsgvo 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/privacy-statement-social-media 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/recruitment-fraud 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/drug-safety-reporting 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/adverse-drug-reaction-form 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/data-protection-notice 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/reporting-form-arabic 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/data-protection-notice-arabic 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/sitemap 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/pain-basics 2024-11-15 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions 2024-11-15 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-management/are-nsaids-compatible-with-other-pain-medications-analgesics 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/initiatives/change-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/initiatives/e-g-g 2025-05-22 daily 0.5 https://www.grunenthal.com/company/products/opioid-products-for-the-treatment-of-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/company/leadership/g-baertschi 2024-08-22 daily 0.5 https://www.grunenthal.com/company/leadership/jan-adams 2024-10-01 daily 0.5 https://www.grunenthal.com/company/leadership/uli-broedl 2025-02-03 daily 0.5 https://www.grunenthal.com/company/leadership/fabian-raschke 2024-08-22 daily 0.5 https://www.grunenthal.com/company/leadership/victor-barbosa 2024-08-22 daily 0.5 https://www.grunenthal.com/company/leadership/leen-hofkens 2024-08-22 daily 0.5 https://www.grunenthal.com/company/leadership/sebastian-koehler 2024-08-22 daily 0.5 https://www.grunenthal.com/company/leadership/quentin-le-masne-de-chermont 2026-03-26 daily 0.5 https://www.grunenthal.com/company/compliance-ethics-transparency/disclosure-of-transfers-of-value 2024-08-22 daily 0.5 https://www.grunenthal.com/company/compliance-ethics-transparency/efpia-disclosure-2024 2025-06-25 daily 0.5 https://www.grunenthal.com/company/compliance-ethics-transparency/efpia-disclosure-2023 2024-08-22 daily 0.5 https://www.grunenthal.com/company/compliance-ethics-transparency/efpia-disclosure-2022 2024-08-22 daily 0.5 https://www.grunenthal.com/company/compliance-ethics-transparency/non-efpia-countries 2025-06-26 daily 0.5 https://www.grunenthal.com/company/partnering/contract-manufacturing-services 2024-08-22 daily 0.5 https://www.grunenthal.com/company/global-capabilities/affiliates-asia 2024-08-22 daily 0.5 https://www.grunenthal.com/company/global-capabilities/affiliates-europe 2025-03-14 daily 0.5 https://www.grunenthal.com/company/global-capabilities/affiliates-usa-latin-america 2024-08-22 daily 0.5 https://www.grunenthal.com/company/global-capabilities/manufacturing-sites 2026-03-09 daily 0.5 https://www.grunenthal.com/responsibility/our-responsibility-approach/covid-19-responsibility-activities 2025-08-20 daily 0.5 https://www.grunenthal.com/science/pain-research-and-development/innovation-hubs 2024-08-22 daily 0.5 https://www.grunenthal.com/science/pipeline/duchenne-muscular-dystrophy 2025-10-02 daily 0.5 https://www.grunenthal.com/science/clinical-trials/data-clinical-trials 2024-10-30 daily 0.5 https://www.grunenthal.com/science/clinical-trials/data-sharing-clinical-trials 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/science-made-me-keith-phillips 2026-02-10 daily 0.5 https://www.grunenthal.com/press-room/stories/growing-a-greener-future-global-reforestation-project 2025-11-25 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-confirmed-as-esg-industry-leader 2025-11-05 daily 0.5 https://www.grunenthal.com/press-room/stories/world-hospice-palliative-care-day-2025 2025-10-10 daily 0.5 https://www.grunenthal.com/press-room/stories/ecovadis-2025-sustainability-rating-gold-medal 2025-10-02 daily 0.5 https://www.grunenthal.com/press-room/stories/leveraging-the-latest-science 2024-09-27 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-mariangeles-caro 2024-09-26 daily 0.5 https://www.grunenthal.com/press-room/stories/cmb-biopharma-growth 2025-09-04 daily 0.5 https://www.grunenthal.com/press-room/stories/go2030-powering-growth-and-future-success 2026-03-25 daily 0.5 https://www.grunenthal.com/press-room/stories/sbti-validation-milestone 2025-08-07 daily 0.5 https://www.grunenthal.com/press-room/stories/employee-portrait-raul-llatas 2025-01-30 daily 0.5 https://www.grunenthal.com/press-room/stories/five-future-facing-facilities 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/go2025-global-operations-transformation 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/stories/integration-excellence-in-action 2026-03-16 daily 0.5 https://www.grunenthal.com/press-room/stories/end-to-end-supply-chain-resilience 2026-03-10 daily 0.5 https://www.grunenthal.com/press-room/stories/sustainable-energy-heat-pumps-mitloedi 2026-03-06 daily 0.5 https://www.grunenthal.com/press-room/stories/employee-portrait-marco-najar 2025-01-23 daily 0.5 https://www.grunenthal.com/press-room/stories/professional-growth-support-for-employees 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/thirty-years-tramadol-production 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-abigail-martinez 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/employee-portrait-alvaro-rodriguez 2025-01-23 daily 0.5 https://www.grunenthal.com/press-room/stories/launch-grunenthal-meds 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/medicines-made-in-latin-america 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-guillermo 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/employee-portrait-sandra-ventura-vasco-lobo 2025-01-23 daily 0.5 https://www.grunenthal.com/press-room/stories/exploring-ways-to-break-the-cycle-of-pain-at-efic-2025 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/new-methodologies-in-pain-research 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/beth-living-with-migraine 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/ten-years-of-family-friendly-support 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/eular2024-patient-collaboration 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-responsibility-report-2024 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/personal-development-approach-through-job-shadowing 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/world-diabetes-day-diabetes-and-pain 2025-01-23 daily 0.5 https://www.grunenthal.com/press-room/stories/building-trust-with-investors 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/great-place-to-work-results-2024 2025-01-23 daily 0.5 https://www.grunenthal.com/press-room/stories/meet-giuseppe-a-pharma-operator 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/karen-living-with-knee-osteoarthritis 2025-01-23 daily 0.5 https://www.grunenthal.com/press-room/stories/twenty-years-e-g-g-jonas-zaman 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-laura 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-receives-top-rating-for-esg-from-sustainalytics 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/research-and-development-operating-model-success-story 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/putting-pain-under-the-microscope 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/twenty-years-e-g-g-joukje-oosterman 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/great-place-to-work-results-2022 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/winners-2025-e-g-g-pain-research-grant 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-joaquin-lopez-ruiz 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-spain-honoured-for-work-in-pain-management 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/world-hospice-and-palliative-care-day 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/e-g-g-2025-application-now-open 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/science-made-me-florian-jakob 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/world-cancer-day-patient-experience-story-carina 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/7500-trees-to-support-our-planet 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-recieves-aa-rating-for-esg-from-msci 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/flood-disaster-gruenenthal-donates-400000-euros-as-emergency-relief 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/the-story-of-grunenthals-global-growth 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/winning-awards-for-commitment-to-quality 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/peru-country-portrait 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/workplace-safety-interview-fuad-mahmood 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/us-pdpn-disease-awareness-campaign-2021 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-production-sites-powered-by-hundred-percent-renewable-electricity 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/new-solar-power-facility-at-aachen-headquarter 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/inclusive-workplace-culture-rodrigo-caceres 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/iasp-world-congress-on-pain-2024 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/acquisition-us-based-valinor-pharma 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/ecovadis-2024-sustainability-rating-gold-medal 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthals-deep-commitment-to-latin-america 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-corporate-reports-2023-24 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-loi 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/connecting-smart-ideas-developing-drugs-with-artificial-intelligence 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/fern-health-expanded-partnership-aims-to-unlock-pioneering-approaches-to-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/science-made-me-chanchal-kumar 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-benjamin 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/100reasons-employee-portrait-magdalena 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-adapts-its-processes-to-new-legislation-against-counterfeit-medicines 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthals-focus-on-patients-making-sure-patients-get-the-medicines-they-need-despite-covid-19 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/building-a-better-future-for-palliative-care-in-latin-america 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-addressing-unmet-medical-needs-in-ecuador-for-nearly-five-decades 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/winners-2023-e-g-g-pain-research-grant 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-acquires-mestex-ag-and-its-phase-iii-ready-investigational-medicine-mtx-071 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/sciencemademe-sebastianschwier 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/successful-us-label-extension-for-qutenza 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/brainmindandpainaward2020 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-is-recognized-for-its-strong-management-of-environmental-social-governance-risks 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/winners-award-ceremony-e-g-g-pain-research-grant-efic-congress-2023 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-gives-volunteer-day 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/increasing-transparency-about-our-interactions-with-the-healthcare-sector 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/change-pain-website-relaunches-with-new-educational-content 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/encouraging-global-results-and-eight-national-certificates-for-grunenthal-great-place-to-work 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-and-partners-conduct-online-survey-to-give-cancer-related-neuropathy-patients-a-voice 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/novartis-presents-partner-of-the-year-award-to-gruenenthals-manufacturing-site-in-ecuador 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/girls-and-women-in-science-interview-head-of-research 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-providing-life-changing-pain-treatments-in-the-nordic-countries 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-esg-risk-rating-2023 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-is-the-leading-provider-of-pain-solutions-in-spain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-colombia-achieves-top-ranking-for-outstanding-logistics 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-supports-world-hospice-and-palliative-care-day-2020 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/interview-nina-furlanic-changepain-initiative 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/peripheral-nop-against-addressing-chronic-peripheral-neuropathic-pain-enters-clinical-development 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/sciencemademe-dalena-brockwell 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/my-green-lab-certification 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/bio-2-treat-gruenenthal-rwth-aachen-university-hospital-team-up-to-tackle-neuropathic-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/partnering-deal-kyowa-kirin-joint-venture 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/delighting-contract-manufacturing-customers-with-high-tech-site-italy 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/partnering-deal-nebido 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/fortieth-anniversary-gruenenthal-chile 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/partnering-deal-rtx 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/exploring-the-human-genome-through-collaborative-research 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/partnering-deal-crestor 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/neuroweg-evaluating-efficacy-in-patients-through-faster-and-more-accurate-test-systems 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/sciencemademe-sarthaksharma 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/diversity-awards-spain 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/one-year-imi-paincare-sharing-insights-into-the-projects-achievements-at-efic 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/how-gruenenthal-employees-are-staying-connected-and-motivated-in-home-office 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/world-hospice-day-quality-of-life-to-the-very-end 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-hormone-production-site-in-chile-awarded-key-brazilian-government-certification 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/partnership-to-develop-innovative-cell-therapy-for-chronic-low-back-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/sciencemademe-mariastupar 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/focusing-on-better-patient-outcomes-at-the-largest-european-pain-congress 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/omar-mossad 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/providing-better-care-for-pain-patients-in-central-america-and-the-caribbean 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/brain-mind-pain-2022-grant-winners 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthals-boston-innovation-hub-boosting-external-innovation 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/efic-gruenenthal-grant-reopened-applications-for-pain-research-grant 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-strong-esg-risk-rating-2022 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/caring-for-the-world-around-us-social-responsibility-at-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/exploring-potential-partnerships-at-jp-morgan-healthcare-conference 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-efic-egg-grant-2023-call-for-applications 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/how-we-promote-hospice-and-palliative-care-worldwide 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/award-winning-corporate-responsiblility-in-mexico 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/what-chronic-pain-means-to-patients-and-society 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthal-reforestation-project-trees-for-our-planet 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/how-can-artificial-intelligence-improve-clinical-trials 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-supports-humanitarian-relief-efforts-in-ukraine 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/sciencemademe-sevildavidson 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-recognises-employees-outstanding-achievements-with-global-excellence-award 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/winners-of-pain-research-grant 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/flagship-initiatives-boost-our-corporate-responsibility-programme 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/imi-project-mobilise-d-mobilisation-as-one-core-aspect-of-pain-management 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/led-bulbs-as-a-shining-example 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/we-are-gruenenthal-our-culture-makes-the-difference 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/joining-forces-for-patient-driven-research-and-development-the-paradigm-initiative 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/bambini-delle-fate-making-a-positive-difference-to-childrens-lives-in-italy 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/new-research-partnership-targets-innovative-treatments-for-neuropathic-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/innovative-research-paradigms-aim-to-better-understand-pain-relief-mechanisms 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/nobel-prize-for-medicine-2021-trpv1 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/palliative-care-dignity-in-the-final-stage-of-life 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/enhanced-disease-understanding-the-pain-pathway-map-fosters-collaborative-pain-research 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/grunenthals-site-in-mitlodi-is-powered-by-green-energy 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/new-medicines-verification-system-we-protect-patients-against-falsified-pharmaceutical-products 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/strong-roots-where-the-heart-is 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-took-part-in-the-annual-jp-morgan-healthcare-conference 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/zero-waste-to-landfill 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-digitally-networked-for-the-benefit-of-patients 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/gruenenthal-aims-to-be-in-the-top-ten-for-clinical-trial-transparency 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/developing-a-diverse-skillset-the-graduate-trainee-program-at-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/listening-to-patients-voices 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/a-golden-opportunity-the-gruenenthal-graduate-program 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/iasp-world-congress-joining-forces-to-change-lives 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/fiftieth-company-anniversary-of-gruenenthals-peruvian-affiliate 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/patient-engagement-in-research-and-development 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/qutenza-phase-iii-psnp-study 2025-07-31 daily 0.5 https://www.grunenthal.com/press-room/stories/collaborate-to-innovate-the-leitmarkt-nrw-program 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/placebo-effect-and-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/the-future-of-pain-medicines-the-leitmarktwettbewerb-lifesciencesnrw-project-neuroweg 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/stories/making-masters-partnership-university-of-duisburg-essen 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2026 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2020 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019 2026-03-20 daily 0.5 https://www.grunenthal.com/press-room/statements/who-inn-tegacorat 2026-02-25 daily 0.5 https://www.grunenthal.com/press-room/statements/media-statement-preliminary-injunction-palexia-retard-germany 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/gruenenthals-response-to-covid-19-the-new-coronavirus 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/wirtz-apologises-on-behalf-of-his-family 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/statement-on-the-recall-of-two-batches-of-anulette-in-chile 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/initial-results-from-mesoblast-phase-three-trial 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/media-statement-recall-of-palexia-oral-solution 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/gruenenthal-terminates-license-supply-agreement-for-zalviso 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/gruenenthal-issues-notice-to-the-ec-and-the-ema-to-withdraw-zurampic-and-duzallo 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/statements/german-federal-parliament-strengthens-legal-certainty-for-thalidomide-affected-people 2024-08-22 daily 0.5 https://www.grunenthal.com/footer-links/medical-information-enquiry/medical-information-enquiry-form-submitted 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/pain-basics/definition-of-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/pain-basics/classification-of-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/pain-basics/pathophysiology 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/pain-basics/comprehensive-assessment 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/pain-basics/management-of-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/pain-basics/unmet-needs 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/chronic-low-back-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/cluster-headache 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/chronic-post-surgical-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/osteoarthritis 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/complex-regional-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/peripheral-neuropathic-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/fibromyalgia 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/migraine 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/neuropathic-low-back-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/world-free-of-pain/pain-insights/key-pain-conditions/cancer-related-neuropathic-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2026/2025-full-year-result-grunenthal 2026-03-27 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2026/grunenthal-licenses-exclusive-south-korean-rights-to-qutenza-to-bcworld-pharm 2026-03-05 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2026/grunenthal-takes-full-ownership-of-grunenthal-meds 2026-03-02 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2026/grunenthal-licenses-exclusive-australian-rights-to-qutenza-to-clinect 2026-02-24 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2026/nav-1-8-inhibitor-enters-clinical-development 2026-02-18 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2026/grunenthal-licenses-exclusive-canadian-rights-for-nebido-to-apotex 2026-02-05 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025/gruenthal-pro-partnership-with-shl-medical 2025-09-04 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025/annoucement-of-acquisition-of-cialis-rights-in-mexico-brazil-colombia 2025-06-02 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025/maren-thurow-appointed-gruenenthal-head-global-communications 2025-05-20 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025/2024-full-year-result-gruenenthal 2025-03-27 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025/qutenza-licensing-agreement-apotex-canada 2025-02-24 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025/prof-dr-uli-broedl-appointed-as-new-gruenenthal-cso 2025-01-09 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2025/grunenthal-pricing-bond-extension-announcement 2025-11-14 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/gruenenthal-reaches-settlement-with-teva-in-us-patent-litigation 2024-12-11 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/gruenenthal-announces-2024-bond-closing 2024-12-06 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/grunenthal-2024-bond-pricing-announcement 2024-11-27 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/completion-of-recruitment-for-phase-iii-qutenza-trial-av001 2024-11-07 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/global-clinical-phase-i-programme-for-nop 2024-10-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/gruenenthal-appoints-jan-adams-as-chief-commercial-officer 2024-09-27 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/grunenthal-acquires-us-company-valinor-pharma 2024-09-27 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/significant-investments-in-latin-american-production-sites 2024-09-27 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2024/2023-full-year-result-gruenenthal 2024-09-27 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/realizedcare-merge-of-behavr-and-fern-health 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/closing-of-joint-venture-with-kyowa-kirin 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/winners-of-pain-research-grant-2023-announced 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/pr-fda-breakthrough-therapy-designation-resiniferatoxin 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/pr-grunenthal-and-kings-college-london-announce-collaboration 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/gruenenthal-announces-bond-closing 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/grunenthal-bond-pricing-announcement 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/2022-full-year-result-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/pr-gruenenthal-catalent-joint-development-milestones 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2023/janneke-van-der-kamp-starts-as-new-gruenenthal-cco 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/grunenthal-kyowa-kirin-international-joint-venture-collaboration-medicines-portfolio 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/janneke-van-der-kamp-grunenthal-new-chief-commercial-officer 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/grunenthal-closes-nebido-deal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/licensing-agreement-shionogi-japan-rtx-osteoarthritis 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/global-clinical-phase-iii-programme-for-resiniferatoxin-rtx 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/research-collaboration-uniklinik-rwth-aachen-and-rwth-aachen-university 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/gruenenthal-acquires-nebido 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/gruenenthal-2021-full-year-results 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/gruenenthal-and-novaquest-enter-development-agreement-for-resiniferatoxin-rtx 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/gruenenthal-makes-donations-to-support-urgent-humanitarian-relief-efforts-in-ukraine 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2022/winners-of-pain-research-grant-2022-announced 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/maren-thurow-joins-gruenenthal-as-head-global-commercial-communication 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/first-participants-enrolled-in-clinical-trial-with-nociceptin-orphanin-peptide-receptor-nop-agonist 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/first-patient-enrolled-in-qutenza-psnp-study 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthals-glucocorticoid-receptor-modulator-enters-clinical-development 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/flood-disaster-gruenenthal-donates-400000-euros-as-emergency-relief 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/gruenenthal-secures-long-term-financing-for-growth-strategy 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/gruenenthal-announces-pricing-of-bond-extension 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/gruenenthal-launches-tap-of-bond-offering 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthal-successfully-places-first-bond 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthal-announces-pricing-of-its-first-bond 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthal-acquires-mestex-ag-and-its-phase-iii-ready-investigational-medicine-mtx-071 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthal-receives-strong-first-environment-social-and-governance-rating 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthal-and-averitas-pharma-announce-initiation-of-phase-iii-study-with-qutenza 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthal-successfully-extends-its-term-loan-bank-facilities 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/grunenthal-closes-deal-with-astrazeneca-for-european-rights-to-crestor 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2021/florian-dieckmann-new-head-global-communications-at-grunenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2020/peripheral-nop-against-addressing-chronic-peripheral-neuropathic-pain-enters-clinical-development 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2020/gruenenthal-agrees-to-acquire-european-rights-to-crestor 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2020/us-fda-approval-of-qutenza-for-the-treatment-of-neuropathic-pain-associated-with-dpn-of-the-feet 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2020/gruenenthal-mit-dem-qualitaetssiegel-audit-berufundfamilie-ausgezeichnet 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2020/pr-gruenenthal-invests-in-e-mobility-at-headquarters-in-aachen 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2020/pr-gruenenthal-expands-network-through-boston-innovation-hub 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-patch 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-jan-adams-appointed-cso-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pm-projekt-bio2treat-neue-forschungsansaetze-chronische-schmerzpatienten 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-gruenenthal-mesoblast-enter-strategic-partnership-innovative-cell-therapy-chronic-low-back-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-egg-research-grant-creative-insights-into-innovative-pain-research 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-gruenenthal-and-uniquest-partner-to-develop-novel-drug-candidates-for-chronic-neuropathic-pain 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pm-neuausrichtung-forschungs-und-entwicklung-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-patient-voice-in-gout-survey-shows-high-unmet-need-and-low-expectations-of-treatment 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-gruenenthal-to-strengthen-core-competencies-in-reseach-and-development 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pm-gruenenthal-staerkt-kernkompetenzen-in-forschung 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-five-young-scientists-win-efic-gruenenthal-grant-2018 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pm-minister-pinkwart-besucht-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.com/press-room/press-releases/2019/pr-fabian-raschke-appointed-new-chief-financial-officer-cfo-gruenenthal 2024-08-22 daily 0.5